New Insights into the Clinical Characterization of SDHAF2 -related Familial Paraganglioma Syndrome
The Journal of Clinical Endocrinology & Metabolism · 16.10.2025 · 110 (11) · e3635-e3647
DOI: 10.1210/clinem/dgaf149 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 13.03.2025. Verfasst von Antia Fernandez-Pombo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Nutrition, University Clinical Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Paraganglioma, Adrenal Gland Neoplasms, Pheochromocytoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Regional Development Fund, European Union.
Abstract (Originalsprache)
Background
The clinical characterization of SDHAF2-related familial paraganglioma syndrome remains elusive. The aim of this study is to contribute to the knowledge of this syndrome with valuable new information.
Methods
A total of 56 individuals with the p.(Gly78Arg) variant in the SDHAF2 gene were prospectively evaluated. Of the 33 subjects who developed paragangliomas (PGLs)/pheochromocytomas (PCs) throughout follow-up, clinical, biochemical, and imaging data were collected. [68Ga]Ga-DOTA-TOC and [18F]DOPA positron emission tomography/computed tomography (PET/CT) scans were carried out on a subset of 22 patients with PGLs/PCs to compare their accuracy; surgical specimens (n = 13) were microscopically evaluated to elucidate their potential malignant behavior.
Results
Of the 33 patients (58.9%) with SDHAF2-related tumors, 17 (51.5%) were women, with a mean age at diagnosis of 38.6 ± 17.2 years. Tumor development was found to be inherited paternally in all subjects. All the patients evaluated except 1 showed head and neck PGLs. Eleven patients (33.3%) showed mediastinal and abdominal extra-adrenal PGLs and 2 patients presented PCs. Multifocality was observed in 26 subjects (78.8%). Sixteen patients (48.5%) were asymptomatic at diagnosis. Only 4 patients with PGLs/PCs showed normetanephrine or 3-methoxytyramine secretion. Metastatic disease was observed in 2 patients (6.1%). Grading System for Adrenal Pheochromocytoma and Paraganglioma score was ≥3 in 84.6% of tumors and Pheochromocytoma of the Adrenal Gland Scaled Score was ≥4 in 69.2%. [68Ga]Ga-DOTA-TOC PET/CT showed a greater detection rate (95.7%) of multifocal PGLs and metastatic lesions than [18F]DOPA PET/CT (79.3%), as well as higher mean maximum standardized uptake value.
Conclusion
The current study offers new insights into the phenotypic characterization of SDHAF2-related paraganglioma syndrome including the development of extra-cervical PGLs and metastatic transformation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Nutrition, University Clinical Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain.
- Unidad de Enfermedades Tiroideas e Metabólicas (UETeM)-Molecular Pathology Group, Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, Center for Research in Molecular Medicine and Chronic Diseases…
- Epigenomics in Endocrinology and Nutrition Group, Epigenomics Unit, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, 15706 Santiago de Compos…
- Division of Nuclear Medicine, University Clinical Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain.
- Department of Pathology, University Clinical Hospital of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela (USC), 15706 Santiago de Compostela, Spai…
- Division of Radiology, University Clinical Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain.
ORCID-Profile: Antia Fernandez-Pombo, Jose Manuel Cameselle-Teijeiro, Virginia Pubul-Nuñez, Marcos Pazos-Couselo, Jose Manuel Cabezas-Agricola
Förderung
- Instituto de Salud Carlos III
- European Regional Development Fund
- European Union
Zitieren
APA
Fernandez-Pombo, A., Nogareda-Seoane, Z., Cameselle-Teijeiro, J. M., Ecenarro-Montiel, A., Vieira-Leite, C., Rodriguez-Carnero, G., Otero-Mato, N., Pubul-Nuñez, V., Pazos-Couselo, M., Loidi, L., & Cabezas-Agricola, J. M. (2025). New Insights into the Clinical Characterization of SDHAF2 -related Familial Paraganglioma Syndrome. The Journal of Clinical Endocrinology & Metabolism, 110(11), e3635-e3647. https://doi.org/10.1210/clinem/dgaf149
Vancouver
Fernandez-Pombo A, Nogareda-Seoane Z, Cameselle-Teijeiro JM, Ecenarro-Montiel A, Vieira-Leite C, Rodriguez-Carnero G, et al. New Insights into the Clinical Characterization of SDHAF2 -related Familial Paraganglioma Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2025;110(11):e3635-e3647. doi:10.1210/clinem/dgaf149
BibTeX
@article{FernandezPombo2025,
author = {Fernandez-Pombo, Antia and Nogareda-Seoane, Zulema and Cameselle-Teijeiro, Jose Manuel and Ecenarro-Montiel, Ana and Vieira-Leite, Cecilia and Rodriguez-Carnero, Gemma and Otero-Mato, Noelia and Pubul-Nuñez, Virginia and Pazos-Couselo, Marcos and Loidi, Lourdes and Cabezas-Agricola, Jose Manuel},
title = {New Insights into the Clinical Characterization of SDHAF2 -related Familial Paraganglioma Syndrome},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {11},
pages = {e3635--e3647},
doi = {10.1210/clinem/dgaf149}
}
EUVIMED